Delivery Order SPE2DB22D2211-SPE2DB25FSEFM
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $55K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,437.40 by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, non-set-aside contract calls for the delivery of XELJANZ XR 11 mg tablets in quantities of 30 units. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,599.24 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,873.07 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 8, 2025, for XELJANZ XR 11 mg tablets (30-count packages). The award, which carries an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for XELJANZ XR 11 mg tablets in 30-count unit doses, valued at $18,565.52 under a firm fixed price contract type. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,776.31 by the Defense Logistics Agency for XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This $9,372.07 firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 28, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, for Xeljanz 5 mg tablets (60-count units) under a firm fixed price contract with a ceiling value of $19,446.19. This is a non-set-aside competitive award funded by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 5, 2025. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $3,331.49 by the Defense Logistics Agency (DLA) to provide XELJANZ 10 MG TABLET UU 60S. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities....
- The Defense Logistics Agency awarded a $4,343.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on July 29, 2025, with completion targeted for July 30, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $33,210.66 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the supply of Xeljanz 5 mg tablets in quantities of 60 units. The contract is firm fixed price with no set-aside designation, indicating competitive award, and carries an ultimate completion date of September 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...